ProfileGDS4718 / 207671_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 52% 51% 53% 53% 40% 45% 49% 57% 46% 47% 56% 50% 45% 49% 44% 46% 47% 45% 64% 40% 42% 51% 49% 49% 43% 50% 52% 60% 49% 47% 41% 54% 47% 46% 52% 46% 49% 51% 53% 43% 52% 47% 43% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8648656
GSM549102patient 115, normal, homogenized [OPG study]5.6274352
GSM549104patient 119, normal, homogenized [OPG study]5.5389451
GSM549108patient 138, normal, homogenized [OPG study]5.7180353
GSM549119patient 077, normal, homogenized [OPG study]5.6926253
GSM549133patient 032, cancer, homogenized [OPG study]4.9221340
GSM549139patient 042, cancer, homogenized [OPG study]5.2199245
GSM549099patient 107, normal, homogenized [OPG study]5.4729549
GSM549109patient 139, normal, homogenized [OPG study]5.9269257
GSM549110patient 046, normal, homogenized [OPG study]5.3183646
GSM549114patient 063, normal, homogenized [OPG study]5.3156847
GSM549122patient 082, normal, homogenized [OPG study]5.8607356
GSM549134patient 033, cancer, homogenized [OPG study]5.4846750
GSM549136patient 036, cancer, homogenized [OPG study]5.195845
GSM549140patient 044, cancer, homogenized [OPG study]5.4034649
GSM549111patient 047, normal, homogenized [OPG study]5.1898944
GSM549113patient 057, normal, homogenized [OPG study]5.2193146
GSM549132patient 031, cancer, homogenized [OPG study]5.3633147
GSM549137patient 038, cancer, homogenized [OPG study]5.2044645
GSM549142patient 047, cancer, homogenized [OPG study]6.441664
GSM549100patient 110, normal, homogenized [OPG study]5.0012440
GSM549107patient 135, normal, homogenized [OPG study]5.0499142
GSM549115patient 068, normal, homogenized [OPG study]5.4964651
GSM549116patient 072, normal, homogenized [OPG study]5.4366449
GSM549120patient 078, normal, homogenized [OPG study]5.4549149
GSM549131patient 030, cancer, homogenized [OPG study]5.075343
GSM549118patient 074, normal, homogenized [OPG study]5.5235850
GSM549129patient 027, cancer, homogenized [OPG study]5.6751952
GSM549123patient 088, normal, homogenized [OPG study]6.1000960
GSM549124patient 006, cancer, homogenized [OPG study]5.4673249
GSM549126patient 015, cancer, homogenized [OPG study]5.3566847
GSM549128patient 025, cancer, homogenized [OPG study]5.0333141
GSM549103patient 117, normal, homogenized [OPG study]5.7674254
GSM549117patient 073, normal, homogenized [OPG study]5.2866747
GSM549138patient 041, cancer, homogenized [OPG study]5.3075146
GSM549141patient 045, cancer, homogenized [OPG study]5.586752
GSM549130patient 028, cancer, homogenized [OPG study]5.3062846
GSM549101patient 111, normal, homogenized [OPG study]5.4655349
GSM549105patient 128, normal, homogenized [OPG study]5.5898551
GSM549106patient 134, normal, homogenized [OPG study]5.6300353
GSM549112patient 048, normal, homogenized [OPG study]5.1526843
GSM549125patient 011, cancer, homogenized [OPG study]5.6296252
GSM549127patient 024, cancer, homogenized [OPG study]5.3347447
GSM549135patient 035, cancer, homogenized [OPG study]5.0940343